LeonMBSmithCRMackM. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–1607.
2.
SmithCRLeonMBMackMJ. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–2198.
3.
Al-LameeRGodinoCColomboA. Transcatheter aortic valve implantation: current principles of patient and technique selection and future perspectives. Circ Cardiovasc Interv. 2011;4(4):387–395.
4.
CribierAEltchaninoffHTronC. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol. 2004;43(4):698–703.
5.
CribierAEltchaninoffHTronC. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol. 2006;47(6):1214–1223.
6.
GrubeESchulerGBuellesfeldL. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol. 2007;50(1):69–76.
7.
Rodes-CabauJWebbJGCheungA. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 2010;55(11):1080–1090.
8.
GenereuxPHeadSJVan MieghemNM. Clinical outcomes after transcatheter aortic valve replacement using Valve Academic Research Consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol. 2012;59(25):2317–2326.
9.
EltchaninoffHPratAGilardM. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J. 2011;32(2):191–197.
10.
Van MieghemNMGenereuxPvan der BoonRM. Transcatheter aortic valve replacement and vascular complications definitions. EuroIntervention. 2014;9(11):1317–1322.
11.
LeonMBPiazzaNNikolskyE. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J. 2011;32(2):205–217.
12.
LeonMBPiazzaNNikolskyE. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol. 2011;57(3):253–269.
13.
KappeteinAPHeadSJGenereuxP. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg. 2013;145(1):6–23.
14.
SinningJMHorackMGrubeE. The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation: results from the German Transcatheter Aortic Valve Interventions Registry. Am Heart J. 2012;164(1):102–110.e1.
15.
LareyreFRaffortJDommercCHabibYBourlonFMialheC. Surgical management of percutaneous transfemoral access to minimize vascular complications related to transcatheter aortic valve implantation. Angiology. 2018;69(2):143–150.
